Open Access

Cerebralcare Granule® attenuates cognitive impairment in rats continuously overexpressing microRNA-30e

  • Authors:
    • Yong Xu
    • Zhifen Liu
    • Xi Song
    • Kerang Zhang
    • Xingrong Li
    • Jianhong Li
    • Xu Yan
    • Yuan Li
    • Zhongchen Xie
    • Hui Zhang
  • View Affiliations

  • Published online on: October 22, 2015     https://doi.org/10.3892/mmr.2015.4469
  • Pages: 8032-8040
  • Copyright: © Xu et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Previous studies have demonstrated that dysregulation of micro (mi)RNAs is associated with the etiology of various neuropsychiatric disorders, including depression and schizophrenia. Cerebralcare Granule® (CG) is a Chinese herbal medicine, which has been reported to have an ameliorative effect on brain injury by attenuating blood‑brain barrier disruption and improving hippocampal neural function. The present study aimed to evaluate the cognitive behavior of rats continuously overexpressing miRNA‑30e (lenti‑miRNA‑30e), prior to and following the administration of CG. In addition, the mechanisms underlying the ameliorative effects of CG were investigated. The cognitive ability of the rats was assessed using an open‑field test and a Morris water maze spatial reference/working memory test. A terminal deoxynucleotidyl transferase dUTP nick end labeling assay was used to detect neuronal apoptosis in the dentate gyrus of the hippocampus. Immunohistochemical analysis and western blotting were conducted to detect the expression levels of B‑cell lymphoma 2 (BCL‑2) and ubiquitin‑conjugating enzyme 9 (UBC9), in order to examine neuronal apoptosis. The lenti‑miRNA‑30e rats exhibited increased signs of anxiety, depression, hyperactivity and schizophrenia, which resulted in a severe impairment in cognitive ability. Furthermore, in the dentate gyrus of these rats, the expression levels of BCL‑2 and UBC9 were reduced and apoptosis was increased. The administration of CG alleviated cognitive impairment, enhanced the expression levels of BCL‑2 and UBC9, and reduced apoptosis in the dentate gyrus in the lenti‑miRNA‑30e rats. No significant differences were detected in behavioral indicators between the lenti‑miRNA‑30e rats treated with CG and the normal controls. These findings suggested that CG exerts a potent therapeutic effect, conferred by its ability to enhance the expression levels of BCL‑2 and UBC9, which inhibits the apoptotic process in neuronal cells. Therefore, CG may be considered a potential therapeutic strategy for the treatment of cognitive impairment in mental disorders.
View Figures
View References

Related Articles

Journal Cover

December-2015
Volume 12 Issue 6

Print ISSN: 1791-2997
Online ISSN:1791-3004

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Xu Y, Liu Z, Song X, Zhang K, Li X, Li J, Yan X, Li Y, Xie Z, Zhang H, Zhang H, et al: Cerebralcare Granule® attenuates cognitive impairment in rats continuously overexpressing microRNA-30e. Mol Med Rep 12: 8032-8040, 2015.
APA
Xu, Y., Liu, Z., Song, X., Zhang, K., Li, X., Li, J. ... Zhang, H. (2015). Cerebralcare Granule® attenuates cognitive impairment in rats continuously overexpressing microRNA-30e. Molecular Medicine Reports, 12, 8032-8040. https://doi.org/10.3892/mmr.2015.4469
MLA
Xu, Y., Liu, Z., Song, X., Zhang, K., Li, X., Li, J., Yan, X., Li, Y., Xie, Z., Zhang, H."Cerebralcare Granule® attenuates cognitive impairment in rats continuously overexpressing microRNA-30e". Molecular Medicine Reports 12.6 (2015): 8032-8040.
Chicago
Xu, Y., Liu, Z., Song, X., Zhang, K., Li, X., Li, J., Yan, X., Li, Y., Xie, Z., Zhang, H."Cerebralcare Granule® attenuates cognitive impairment in rats continuously overexpressing microRNA-30e". Molecular Medicine Reports 12, no. 6 (2015): 8032-8040. https://doi.org/10.3892/mmr.2015.4469